Status:
NOT_YET_RECRUITING
Fat Injection for Rectocele Treatment: A Novel Approach
Lead Sponsor:
Cairo University
Conditions:
Rectocele
Pelvic Organ Prolapse
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
This clinical trial aims to evaluate the effectiveness of autologous fat grafting as a novel treatment for rectocele, a condition characterized by the herniation of rectal tissue into the posterior va...
Eligibility Criteria
Inclusion
- Female patients aged between 18 and 60 years.
- Diagnosis of rectocele confirmed by defecography, with a rectocele size of 2 cm (mild) to 4 cm (moderate).
- Presenting with symptoms of obstructive defecation syndrome, including constipation, incomplete defecation, and/or vaginal bulge.
- Able to provide written informed consent to participate in the study.
Exclusion
- Patients who have previously undergone surgical repair of rectocele.
- Presence of thrombosed hemorrhoids.
- History of sclerotherapy injection for rectocele.
- Diagnosis of anal stenosis.
- History of coagulopathy or current use of anticoagulant or antiplatelet medications.
- Refusal or inability to provide informed consent.
Key Trial Info
Start Date :
October 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 20 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06604702
Start Date
October 20 2024
End Date
October 20 2025
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.